Enfusion Inc. (ENFN)
NYSE: ENFN
· Real-Time Price · USD
10.76
-0.04 (-0.37%)
At close: Apr 17, 2025, 3:59 PM
Enfusion Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 201.61M | 195.16M | 188.35M | 181.62M | 174.53M | 168.57M | 163.36M | 157.18M | 150.35M | 141.69M | 131.58M | 121.49M | 111.7M | 102.51M | 93.25M | 85.36M |
Cost of Revenue | 64.87M | 64.1M | 62.27M | 60.51M | 57.64M | 55.31M | 52.78M | 49.42M | 47.1M | 43.97M | 40.09M | 36.02M | 31.84M | 27.84M | 25.14M | 23.26M |
Gross Profit | 136.74M | 131.06M | 126.08M | 121.1M | 116.89M | 113.25M | 110.58M | 107.76M | 103.25M | 97.72M | 91.49M | 85.47M | 79.86M | 74.67M | 68.11M | 62.09M |
Operating Income | 6.16M | 6.71M | 6.41M | 6.16M | 11.95M | 11.19M | 11.44M | 5.09M | -11.96M | -305.83M | -303.87M | -294.06M | -275.88M | 4.7M | 5.96M | 5.97M |
Interest Income | 1.69M | 2.8M | 2.31M | 2.42M | 2.6M | 1.38M | 1.38M | 916K | 424K | n/a | n/a | n/a | n/a | n/a | n/a | 364K |
Pretax Income | 7.39M | 7.11M | 7.28M | 5.52M | 11.48M | 10.51M | 10.37M | 5.28M | -12.19M | -307.41M | -306.85M | -298.45M | -281.66M | -52K | 2.31M | 3.36M |
Net Income | 2.82M | 3.33M | 3.74M | 2.54M | 7.77M | 7.94M | 8.71M | 5.66M | -11.56M | -306.24M | -305.55M | -298.87M | -282.24M | -534K | 1.75M | 2.84M |
Selling & General & Admin | 103.86M | 98.8M | 96.03M | 92.93M | 85.05M | 83.46M | 81.61M | 85.88M | 98.05M | 244.61M | 237.68M | 223.53M | 202.34M | 61.33M | 54.46M | 49.05M |
Research & Development | 26.73M | 25.55M | 23.64M | 22.01M | 19.89M | 18.61M | 17.53M | 16.79M | 17.16M | 158.94M | 157.68M | 156M | 153.4M | 8.64M | 7.68M | 7.08M |
Other Expenses | -193K | -193K | -193K | -82K | n/a | n/a | -52K | -51K | -48K | -1.26M | -1.18M | -1.18M | -1.19M | 110K | 81K | 81K |
Operating Expenses | 130.58M | 124.35M | 119.67M | 114.95M | 104.95M | 102.07M | 99.14M | 102.67M | 115.21M | 403.55M | 395.36M | 379.52M | 355.74M | 69.97M | 62.15M | 56.13M |
Interest Expense | n/a | 303K | 303K | 303K | 303K | 424K | 428K | 429K | 435K | 318K | 1.8M | 3.21M | 4.59M | 4.86M | 3.74M | 2.33M |
Selling & Marketing Expenses | 25.03M | 24.01M | 23.29M | 22.55M | 20.42M | 20.87M | 22.64M | 24.94M | 29.29M | 62.69M | 60.31M | 57M | 51.73M | 15.63M | 12.8M | 10.81M |
Cost & Expenses | 195.46M | 188.45M | 181.94M | 175.46M | 162.59M | 157.38M | 151.92M | 152.09M | 162.31M | 447.52M | 435.45M | 415.54M | 387.58M | 97.81M | 87.28M | 79.39M |
Income Tax Expense | 3.52M | 2.47M | 1.93M | 1.72M | 2.23M | 1.37M | 1.29M | 1.32M | 1.07M | 531K | 398K | 428K | 580K | 482K | 556K | 521.5K |
Shares Outstanding (Basic) | 94.26M | 92.9M | 92.38M | 89.51M | 88.28M | 87.74M | 88.31M | 88.86M | 88.02M | 86.3M | 84.58M | 79.81M | 83.17M | 64.07M | 64.07M | 64.07M |
Shares Outstanding (Diluted) | 129.56M | 128.98M | 128.85M | 128.31M | 127.77M | 127.84M | 129.86M | 132.35M | 132.95M | 131.76M | 84.58M | 83.38M | 83.17M | 64.07M | 64.07M | 64.07M |
EPS (Basic) | 0.04 | 0.04 | 0.04 | 0.03 | 0.09 | 0.09 | 0.10 | 0.06 | -0.15 | -3.69 | -3.67 | -3.57 | -3.35 | -0.01 | 0.03 | 0.04 |
EPS (Diluted) | 0.02 | 0.03 | 0.03 | 0.02 | 0.06 | 0.06 | 0.07 | 0.03 | -0.15 | -3.69 | -3.66 | -3.56 | -3.35 | -0.01 | 0.03 | 0.04 |
EBITDA | 14.54M | 17.61M | 14.47M | 12.63M | 15.74M | 13.46M | 15.41M | 9.39M | -6.32M | -301.08M | -300.81M | -291.7M | -274.11M | 7.12M | 8.82M | 8.25M |
EBIT | 6.16M | 6.67M | 6.72M | 5.2M | 11.41M | 10.68M | 10.59M | 5.5M | -11.96M | -307.05M | -305.09M | -295.27M | -277.1M | 4.78M | 6.05M | 6.05M |
Depreciation & Amortization | 8.51M | 10.62M | 12.16M | 14.66M | 13.82M | 13.65M | 10.85M | 7.09M | 6.6M | 5.97M | 5.26M | 4.56M | 3.98M | 3.33M | 3.6M | 3.03M |